PDGFR‐β and kidney fibrosis
Abstract Chronic kidney disease (CKD) is one of the fastest growing global causes of death, estimated to rank among the top five by 2040 (Foreman et al, 2018). This illustrates current pitfalls in diagnosis and management of CKD. Advanced CKD requires renal function replacement by dialysis or transp...
Main Author: | Alberto Ortiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2020-02-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.201911729 |
Similar Items
-
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
by: Eva M Buhl, et al.
Published: (2020-01-01) -
Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
by: Lingli Zhou, et al.
Published: (2018-07-01) -
Transactivation of PDGFRβ by dopamine D4 receptor does not require PDGFRβ dimerization
by: Chi Sum, et al.
Published: (2010-07-01) -
Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis
by: Xingqi Wang, et al.
Published: (2016-05-01) -
Double Labeling of PDGFR-β and α-SMA in Swine Models of Acute Kidney Injury to Detect Pericyte-to-Myofibroblast Transdifferentation as Early Marker of Fibrosis
by: Alessandra Stasi, et al.
Published: (2020-10-01)